Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4Pancreatic Neoplasms 2Disease Progression 1Colonic Neoplasms 1Cancer That is Associated With a Chronic Viral Infection 1

Interventions

durvalumab 2Nivolumab 2Gemcitabine 2tremelimumab 1regorafenib 1nilotinib 1neratinib 1encorafenib 1Valproic Acid 1Taxes 1Standard of Care 1Radiomics 1Practice Guidelines as Topic 1Palliative Care 1Oxaliplatin 1Leucovorin 1Hepatectomy 1Folfox protocol 1Fluorouracil 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1Clinical Trials as Topic 1Cisplatin 1Cetuximab 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Progression × Valproic Acid × Gastrointestinal × Clear all
NCT03919292 2026-04-21

Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

Virginia Commonwealth University

Phase 1/2 Recruiting
83 enrolled
Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡